California Proposition 71 (2004)

California Proposition 71 (2004), officially titled the California Stem Cell Research and Cures Act, was a ballot initiative approved by voters to authorize the state to issue general obligation bonds for stem cell research. The measure established the California Institute for Regenerative Medicine (CIRM) to oversee grants and created new state constitutional rights to conduct research. It was a direct response to federal funding restrictions imposed by the George W. Bush administration on embryonic stem cell research, aiming to position California as a global leader in the field.

Background and intent

The initiative emerged during a period of intense national debate over the ethics of embryonic stem cell research. In August 2001, President George W. Bush announced federal policy limiting National Institutes of Health funding to research on existing stem cell lines. This decision was criticized by many in the scientific community, including prominent researchers at institutions like Stanford University and the University of California, San Francisco, who argued it severely hampered progress toward potential treatments for diseases such as Parkinson's disease, Alzheimer's disease, and spinal cord injury. Proponents, including patient advocates and biotechnology leaders, framed the measure as a necessary state-level intervention to bypass federal restrictions and accelerate medical discovery. The campaign was largely driven by figures like Robert N. Klein, a real estate investor and patient advocate, who became its primary financier and spokesperson.

Provisions of the measure

Proposition 71 amended both the California Constitution and state statutes. Its core provision authorized the sale of $3 billion in general obligation bonds over ten years to fund stem cell research, primarily focusing on embryonic stem cell studies but also permitting work on other types like adult stem cells. The measure created the California Institute for Regenerative Medicine (CIRM), a new state agency governed by an independent 29-member Independent Citizens' Oversight Committee (ICOC) appointed from specified universities, research institutes, and disease advocacy groups. The state legislature was explicitly prohibited from altering the institute's funding or operations for the first three years. The act also established a constitutional right to conduct stem cell research within state law, provided it complied with specific ethical standards, including a ban on human reproductive cloning.

Campaign and support

The "Yes on 71" campaign was one of the most expensive ballot initiative campaigns in California history at the time, raising over $35 million. Major financial support came from individuals like Robert N. Klein and Eli Broad, as well as institutions including Stanford University, the University of California, and several biotechnology companies. The campaign coalition, Californians for Stem Cell Research and Cures, featured high-profile endorsements from figures such as actor Michael J. Fox, who has Parkinson's disease, former First Lady Nancy Reagan, and numerous Nobel laureates like Paul Berg. Messaging focused on the promise of cures for chronic diseases and the economic benefits of keeping California competitive in biomedical research, effectively leveraging patient stories and the prestige of the state's academic and technology sectors.

Opposition and criticism

Opposition was led by groups including the California Catholic Conference, the Center for Bioethics and Culture Network, and some fiscal conservatives. Critics raised multiple concerns: the ethical objection to the destruction of human embryos for research; the fiscal imprudence of committing the state to massive debt through general obligation bonds during a budget crisis; and the lack of legislative oversight for the new agency. Organizations like the Howard Jarvis Taxpayers Association argued it created an unconstitutional delegation of power to an unelected body. Some scientists and economists, including a group from the University of California, Berkeley, also questioned the measure's financial structure and the potential for conflicts of interest within the appointed Independent Citizens' Oversight Committee.

Results and impact

On November 2, 2004, Proposition 71 passed with 59.1% of the vote. It performed strongly in populous coastal counties like Los Angeles and the San Francisco Bay Area, while more conservative inland counties largely voted against it. The immediate impact was the creation of the California Institute for Regenerative Medicine (CIRM), which began awarding grants to researchers at institutions across the state, including the University of California, San Diego, the Salk Institute for Biological Studies, and Cedars-Sinai Medical Center. The vote was seen as a significant political rebuke to the policies of the George W. Bush administration and spurred similar, though smaller, state-level initiatives in places like New York and Connecticut.

Legal and financial challenges

The implementation of Proposition 71 was immediately delayed by lawsuits. Two major cases, ** and **, challenged the constitutionality of the agency's structure, arguing it violated state oversight provisions. Although the California Supreme Court ultimately upheld the measure in 2007, the litigation froze bond sales for nearly two years. Further financial challenges emerged from the Great Recession, which increased the state's cost of borrowing and strained its general fund due to the structure of the general obligation bonds. These delays and costs significantly reduced the actual funds available for research compared to initial projections and prompted ongoing debates about the agency's governance and financial accountability.